NEW YORK — A securities class action lawsuit has been launched against Lantheus Holdings, Inc., a company listed on NASDAQ under the symbol LNTH. The complaint, filed by a shareholder, seeks to represent investors who acquired Lantheus securities between February 26 and August 5, 2025.
The lawsuit alleges that the defendants made false statements regarding the competitive standing of Lantheus’s key product, Pylarify, a radiopharmaceutical used in oncology. Investors who believe they have been affected by these misrepresentations are urged to consider their legal options.
Shareholders who bought Lantheus securities during the specified period and suffered financial losses may find it beneficial to join the class action. Individuals interested in discussing their legal rights can visit the firm’s website or contact Investor Relations Manager Peter Allocco directly.
Those wishing to serve as lead plaintiff must submit the necessary documents by November 10, 2025. The role of lead plaintiff involves representing the class in directing the litigation process, though participation in any potential recovery does not require serving in this capacity.
Representation from Bernstein Liebhard LLP, the law firm handling the suit, is provided on a contingency fee basis, meaning that no out-of-pocket fees will be charged to shareholders. The firm has a long track record, having recovered over $3.5 billion for clients since its inception in 1993. It has also earned recognition from prominent legal publications for its class action litigation efforts.
Lantheus Holdings, Inc. is currently navigating these allegations as investors weigh their options amidst the ongoing legal proceedings. More information regarding the lawsuit and details for prospective plaintiffs can be gleaned from Bernstein Liebhard LLP’s official communications.
This automated article has been produced by Open AI, and while it strives for accuracy, the details may not fully reflect the situation. Any inaccuracies can be addressed by reaching out via email at contact@publiclawlibrary.org.